Europe
The sale of Germany-based Breath comes after the company launched two late-stage trials assessing its lead product as a treatment for a disease that affects lung transplant patients.
BioCity, a pioneering life science incubator and business collective, has announced a new strategic partnership with Oxford AHSN.
Arcis Biotechnology, the nucleic acid sample preparation solution provider, announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors.
Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation technologies, provides a trading update for the six month period ended 30 June 2019.
Double-digit sales growth delivered by Pharma Biotech & Nutrition (LPBN) segment
Expansion to bioconjugation facility in Visp, Switzerland to meet increasing clinical, launch and commercial market demand
Biotech and pharma companies from across the globe provide updates on company strategy and pipeline developments.
The Fund has now invested a total of USD 30 million in six companies
MetrioPharm AG, a pharmaceutical development company, welcomes Sven Zimmermann, as its new Chief Financial Officer, bringing more than a decade of experience in strategic transactions.
The academic hematology department of Erasmus Medical Center is globally the first hospital to offer every multiple myeloma patient an innovative diagnostic service that predicts the aggressiveness of the disease by measuring 92 genes in the cancer cells
PRESS RELEASES